comparemela.com

Latest Breaking News On - வைப்புத்தொகை ஆர்வங்கள் - Page 2 : comparemela.com

Besra Gold Inc : Besra Gold Inc: Announces Lodgment of Prospectus & Application for ASX Listing

Besra Gold Inc.: Besra Gold Inc: Announces Lodgment of Prospectus & Application for ASX Listing Besra or the Company ), announces today that it has lodged with the Australian Securities and Investments Commission ( ASIC ) its prospectus to raise between A$10 million and A$12.5 million by the issue of between 50,000,000 and 62,500,000 Chess Depository Interests ( CDIs ) (each CDI will represent one common share in Besra) by Besra at A$0.20 per CDI ( Offer ) Application has also been made to the Australian Securities Exchange ( ASX ) to list the CDIs. The Offer is being arranged by Canaccord Genuity (Australia) Limited. Funds raised pursuant to the Offer will be used primarily to significantly advance drilling and development plans at the Company s Bau gold project in E. Malaysia.

Investegate |AIM Announcements | AIM: Schedule One

Investegate |AIM Announcements | AIM: Schedule One
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

Investegate |MaxCyte, Inc Announcements | MaxCyte, Inc : MaxCyte Announces £40 million Subscription

About MaxCyte MaxCyte is a world-leading provider of cell-engineering enabling technology and is responsible for helping to bring next-generation cell and gene-editing therapies to life. The Company s technology is deployed by leading drug developers worldwide, including all of the top ten global biopharmaceutical companies. MaxCyte licences have been granted for more than 140 cell therapy programmes, with more than 100 licensed for clinical use, and the Company has now entered into twelve clinical/commercial license partnerships with leading cell therapy and gene editing developers. MaxCyte was founded in 1998, is listed on the London Stock Exchange (LSE: MXCT, MXCL) and is headquartered in Gaithersburg, Maryland, US. For more information, visit www.maxcyte.com.

Investegate |European Metals Hldg Announcements | European Metals Hldg: Issue of Equity

A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body; 4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.